Related Experiment Video

Updated: Jun 28, 2026

Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach
10:01

Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach

Published on: June 23, 2026

Simulations of a specific inhibitor of the dishevelled PDZ domain

Xin Chen1, Yuefan Deng

  • 1Department of Physics, Stony Brook University, Stony Brook, NY 11794, USA.

Journal of Molecular Modeling
|October 28, 2008
PubMed

Insights

Researchers found an organic molecule that binds to the dishevelled (Dvl) PDZ domain, crucial for Wnt signaling in development and cancer. Molecular dynamics simulations analyzed this interaction, offering insights into potential therapeutic strategies.

Area of Science:

  • Molecular biology
  • Biochemistry
  • Computational chemistry

Background:

  • The dishevelled (Dvl) PDZ domain is vital for Wnt signaling pathways, impacting embryonic development and cancer.
  • Dvl proteins interact with frizzled (Fz) receptors, mediating signal transduction.
  • Dysregulation of Wnt signaling is implicated in various human diseases, including cancer.

Purpose of the Study:

  • To investigate the binding interaction between the Dvl PDZ domain and an identified small molecule inhibitor, NSC668036.
  • To analyze the molecular dynamics of the Dvl PDZ domain-NSC668036 complex.
  • To provide a structural basis for understanding Dvl PDZ domain inhibition.

Main Methods:

  • Utilized molecular dynamics (MD) simulations.
  • Analyzed the binding affinity and stability of NSC668036 to the Dvl PDZ domain.
  • Characterized the key interactions and conformational changes during binding.

Main Results:

  • NSC668036 demonstrated stable binding to the Dvl PDZ domain.
  • MD simulations revealed specific interactions stabilizing the complex.
  • The study identified key residues involved in the binding interface.

Conclusions:

  • NSC668036 acts as a potential inhibitor of the Dvl PDZ domain.
  • The findings offer insights into targeting Wnt signaling pathways for therapeutic interventions.
  • This research provides a foundation for developing novel anti-cancer drugs targeting Dvl.

More Related Videos

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

Analysis of Group IV Viral SSHHPS Using In Vitro and In Silico Methods10:40

Analysis of Group IV Viral SSHHPS Using In Vitro and In Silico Methods

Published on: December 21, 2019

Related Concept Videos

Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...